Trials see no cognitive benefit from semaglutide for Alzheimer's Modest improvement seen in about a quarter of measured biomarkers Safety and tolerability consistent with previous trials SAN DIEGO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback